Avoid common mistakes on your manuscript.
Dear Sir: The quest for a reliable diagnostic marker of ventilator-associated pneumonia (VAP) is still ongoing and whether determination of the alveolar concentration of the soluble form of the triggering receptor expressed on myeloid cells (TREM)-1 could be a valuable candidate is debated. Unfortunately, the study reported in this issue of Intensive Care Medicine will just generate further perplexity [1].
First, the presented work is the result of an ancillary study originating from the series reported last year in this same journal [2], which the authors should have clearly acknowledged. This fact raises concerns regarding the quality of the samples’ conservation (since 2001) especially if they have been subject to freeze/thaw cycles that rapidly degrade sTREM-1. Because alveolar sampling was initially not dedicated to sTREM-1 measurement, bronchoalveolar lavage (BAL) fluid was centrifuged at 250g for 10 min, a procedure largely insufficient to eliminate cell particulates that express membrane-bound TREM-1 (alveolar macrophages or neutrophils): this may have led to artificially increased sTREM-1 concentrations.
Second, the effects of previous antibiotherapy of the diagnosis of VAP are not discussed. VAP was diagnosed by the presence of ≥2% cells containing intracellular organisms (ICO) or quantitative culture of ≥104 cfu/ml. Although previous antibiotics do not seem to interfere with ICO percentage [2], this is obviously not the case for quantitative cultures. Unfortunately, no data are presented on the number of VAP diagnosed by ICO percentage or quantitative culture: a subset of patients may have been classified as no VAP just because <2% ICO and <104 cfu/ml were observed while antibiotics were given. By the way, we have no idea on the final diagnosis that was retained in the no-VAP patients.
Despite the fact that all these limitations by themselves preclude the drawing of any conclusion, another problematic issue must be pointed out. The authors used a commercially available assay, namely the human TREM-1 Quantikine assay from RnD Systems (Minneapolis, USA), to measure sTREM-1 concentrations. It happens that this assay was recalled by RnD systems during the early summer of 2008 because of its inability to properly measure soluble TREM-1 concentration. I want to believe that the authors were not aware of that.
Of note, the three studies [3–5] reporting good performances of BAL sTREM-1 measurement in diagnosing VAP used an ELISA technique (Duoset, RnD Systems) different from the one employed in the two studies [1, 6] showing limited sTREM-1 usefulness (Quantikine).
It may well be that sTREM-1 measurement will finally prove to be disappointing in diagnosing VAP, but the current study is just not interpretable.
References
Oudhuis GF, Beuving J, Bergmans D, Stobberingh EE, ten Velde G, Linssen CF, Verbon A (2009) Soluble triggering receptor expressed on myeloid cells-1 in bronchoalveolar lavage fluid is not predictive for ventilator-associated pneumonia. Intensive Care Med. doi: 10.1007/s00134-009-1463-y
Linssen CF, Jacobs JA, Schouten JS, van Mook WN, Ramsay G, Drent M (2008) Influence of antibiotic therapy on the cytological diagnosis of ventilator-associated pneumonia. Intensive Care Med 34:865–872
Determann RM, Millo JL, Gibot S, Korevaar JC, Vroom MB, van der Poll T, Garrard CS, Schultz MJ (2005) Serial changes in soluble triggering receptor expressed on myeloid cells in the lung during development of ventilator-associated pneumonia. Intensive Care Med 31:1495–1500
Huh JW, Lim CM, Koh Y, Oh YM, Shim TS, Lee SD, Kim WS, Kim DS, Kim WD, Hong SB (2008) Diagnostic utility of the soluble triggering receptor expressed on myeloid cells-1 in bronchoalveolar lavage fluid from patients with bilateral lung infiltrates. Crit Care 12:R6
El-Sohl A, Akinnussi ME, Peter M, Berim I, Schultz MJ, Pineda L (2008) Triggering receptors expressed on myeloid cells in pulmonary aspiration syndromes. Intensive Care Med 34:1012–1019
Anand NJ, Zuick S, Klesney-Tait J, Kollef MH (2009) Diagnostic implications of soluble triggering receptor expressed on myeloid cells-1 in BAL fluid of patients with pulmonary infiltrates in the ICU. Chest 135:641–647
Conflict of interest statement
No conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Additional information
Comment on “Soluble Triggering Receptor Expressed on Myeloid cells-1 in bronchoalveolar lavage fluid is not predictive for ventilator-associated pneumonia.” Published in Intensive Care Medicine (doi:10.1007/s00134-009-1463-y).
An author’s reply to this comment is available at: doi:10.1007/s00134-009-1548-7.
Rights and permissions
About this article
Cite this article
Gibot, S. Soluble triggering receptor expressed on myeloid cells-1 and diagnosis of ventilator-associated pneumonia. Intensive Care Med 35, 1644 (2009). https://doi.org/10.1007/s00134-009-1547-8
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00134-009-1547-8